aluates Reports

$ 0.0

Automative

Global Soliris (Eculizumab) Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-9C2608

Global Soliris Eculizumab Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Soliris (Eculizumab) Market Research Report 2025

Code: QYRE-Auto-9C2608

Report

April 2025

Pages:61

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Alexion

Soliris (Eculizumab) Market

The global market for Soliris (Eculizumab) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. Eculizumab was the first drug approved for each of its uses, and its approval was granted on the basis of small clinical trials.

In Asia-Pacific, Japan is the largest Soliris (Eculizumab) market with about 32% market share. China is follower, accounting for about 25% market share.The key manufacturers are Alexion etc.

This report aims to provide a comprehensive presentation of the global market for Soliris (Eculizumab), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Soliris (Eculizumab).

The Soliris (Eculizumab) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Soliris (Eculizumab) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Soliris (Eculizumab) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Soliris (Eculizumab) Market Report

Report Metric	Details
Report Name	Soliris (Eculizumab) Market
Segment by Type	Plasma Exchange Plasma Infusion
Segment by Application	PNH aHUS Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Alexion
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Soliris (Eculizumab) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

What is the Soliris (Eculizumab) Market share by region?

Ans: China is follower, accounting for about 25% market share.

Who are the main players in the Soliris (Eculizumab) Market report?

Ans: The main players in the Soliris (Eculizumab) Market are Alexion

What are the Application segmentation covered in the Soliris (Eculizumab) Market report?

Ans: The Applications covered in the Soliris (Eculizumab) Market report are PNH, aHUS, Others

What are the Type segmentation covered in the Soliris (Eculizumab) Market report?

Ans: The Types covered in the Soliris (Eculizumab) Market report are Plasma Exchange, Plasma Infusion

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Soliris (Eculizumab) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Plasma Exchange

1.2.3 Plasma Infusion

1.3 Market by Application

1.3.1 Global Soliris (Eculizumab) Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 PNH

1.3.3 aHUS

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Soliris (Eculizumab) Market Perspective (2020-2031)

2.2 Global Soliris (Eculizumab) Growth Trends by Region

2.2.1 Global Soliris (Eculizumab) Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Soliris (Eculizumab) Historic Market Size by Region (2020-2025)

2.2.3 Soliris (Eculizumab) Forecasted Market Size by Region (2026-2031)

2.3 Soliris (Eculizumab) Market Dynamics

2.3.1 Soliris (Eculizumab) Industry Trends

2.3.2 Soliris (Eculizumab) Market Drivers

2.3.3 Soliris (Eculizumab) Market Challenges

2.3.4 Soliris (Eculizumab) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Soliris (Eculizumab) Players by Revenue

3.1.1 Global Top Soliris (Eculizumab) Players by Revenue (2020-2025)

3.1.2 Global Soliris (Eculizumab) Revenue Market Share by Players (2020-2025)

3.2 Global Soliris (Eculizumab) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Soliris (Eculizumab) Revenue

3.4 Global Soliris (Eculizumab) Market Concentration Ratio

3.4.1 Global Soliris (Eculizumab) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Soliris (Eculizumab) Revenue in 2024

3.5 Global Key Players of Soliris (Eculizumab) Head office and Area Served

3.6 Global Key Players of Soliris (Eculizumab), Product and Application

3.7 Global Key Players of Soliris (Eculizumab), Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Soliris (Eculizumab) Breakdown Data by Type

4.1 Global Soliris (Eculizumab) Historic Market Size by Type (2020-2025)

4.2 Global Soliris (Eculizumab) Forecasted Market Size by Type (2026-2031)

5 Soliris (Eculizumab) Breakdown Data by Application

5.1 Global Soliris (Eculizumab) Historic Market Size by Application (2020-2025)

5.2 Global Soliris (Eculizumab) Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Soliris (Eculizumab) Market Size (2020-2031)

6.2 North America Soliris (Eculizumab) Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Soliris (Eculizumab) Market Size by Country (2020-2025)

6.4 North America Soliris (Eculizumab) Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Soliris (Eculizumab) Market Size (2020-2031)

7.2 Europe Soliris (Eculizumab) Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Soliris (Eculizumab) Market Size by Country (2020-2025)

7.4 Europe Soliris (Eculizumab) Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Soliris (Eculizumab) Market Size (2020-2031)

8.2 Asia-Pacific Soliris (Eculizumab) Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Soliris (Eculizumab) Market Size by Region (2020-2025)

8.4 Asia-Pacific Soliris (Eculizumab) Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Soliris (Eculizumab) Market Size (2020-2031)

9.2 Latin America Soliris (Eculizumab) Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Soliris (Eculizumab) Market Size by Country (2020-2025)

9.4 Latin America Soliris (Eculizumab) Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Soliris (Eculizumab) Market Size (2020-2031)

10.2 Middle East & Africa Soliris (Eculizumab) Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Soliris (Eculizumab) Market Size by Country (2020-2025)

10.4 Middle East & Africa Soliris (Eculizumab) Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Alexion

11.1.1 Alexion Company Details

11.1.2 Alexion Business Overview

11.1.3 Alexion Soliris (Eculizumab) Introduction

11.1.4 Alexion Revenue in Soliris (Eculizumab) Business (2020-2025)

11.1.5 Alexion Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Alexion

List of Tables

Table 1. Global Soliris (Eculizumab) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Plasma Exchange

Table 3. Key Players of Plasma Infusion

Table 4. Global Soliris (Eculizumab) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Soliris (Eculizumab) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Soliris (Eculizumab) Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Soliris (Eculizumab) Market Share by Region (2020-2025)

Table 8. Global Soliris (Eculizumab) Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Soliris (Eculizumab) Market Share by Region (2026-2031)

Table 10. Soliris (Eculizumab) Market Trends

Table 11. Soliris (Eculizumab) Market Drivers

Table 12. Soliris (Eculizumab) Market Challenges

Table 13. Soliris (Eculizumab) Market Restraints

Table 14. Global Soliris (Eculizumab) Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Soliris (Eculizumab) Market Share by Players (2020-2025)

Table 16. Global Top Soliris (Eculizumab) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soliris (Eculizumab) as of 2024)

Table 17. Ranking of Global Top Soliris (Eculizumab) Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Soliris (Eculizumab) Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Soliris (Eculizumab), Headquarters and Area Served

Table 20. Global Key Players of Soliris (Eculizumab), Product and Application

Table 21. Global Key Players of Soliris (Eculizumab), Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Soliris (Eculizumab) Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Soliris (Eculizumab) Revenue Market Share by Type (2020-2025)

Table 25. Global Soliris (Eculizumab) Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Soliris (Eculizumab) Revenue Market Share by Type (2026-2031)

Table 27. Global Soliris (Eculizumab) Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Soliris (Eculizumab) Revenue Market Share by Application (2020-2025)

Table 29. Global Soliris (Eculizumab) Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Soliris (Eculizumab) Revenue Market Share by Application (2026-2031)

Table 31. North America Soliris (Eculizumab) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Soliris (Eculizumab) Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Soliris (Eculizumab) Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Soliris (Eculizumab) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Soliris (Eculizumab) Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Soliris (Eculizumab) Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Soliris (Eculizumab) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Soliris (Eculizumab) Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Soliris (Eculizumab) Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Soliris (Eculizumab) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Soliris (Eculizumab) Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Soliris (Eculizumab) Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Soliris (Eculizumab) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Soliris (Eculizumab) Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Soliris (Eculizumab) Market Size by Country (2026-2031) & (US$ Million)

Table 46. Alexion Company Details

Table 47. Alexion Business Overview

Table 48. Alexion Soliris (Eculizumab) Product

Table 49. Alexion Revenue in Soliris (Eculizumab) Business (2020-2025) & (US$ Million)

Table 50. Alexion Recent Development

Table 51. Research Programs/Design for This Report

Table 52. Key Data Information from Secondary Sources

Table 53. Key Data Information from Primary Sources

Table 54. Authors List of This Report

List of Figures

Figure 1. Soliris (Eculizumab) Picture

Figure 2. Global Soliris (Eculizumab) Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Soliris (Eculizumab) Market Share by Type: 2024 VS 2031

Figure 4. Plasma Exchange Features

Figure 5. Plasma Infusion Features

Figure 6. Global Soliris (Eculizumab) Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Soliris (Eculizumab) Market Share by Application: 2024 VS 2031

Figure 8. PNH Case Studies

Figure 9. aHUS Case Studies

Figure 10. Others Case Studies

Figure 11. Soliris (Eculizumab) Report Years Considered

Figure 12. Global Soliris (Eculizumab) Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Soliris (Eculizumab) Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Soliris (Eculizumab) Market Share by Region: 2024 VS 2031

Figure 15. Global Soliris (Eculizumab) Market Share by Players in 2024

Figure 16. Global Top Soliris (Eculizumab) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soliris (Eculizumab) as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Soliris (Eculizumab) Revenue in 2024

Figure 18. North America Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Soliris (Eculizumab) Market Share by Country (2020-2031)

Figure 20. United States Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Soliris (Eculizumab) Market Share by Country (2020-2031)

Figure 24. Germany Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Soliris (Eculizumab) Market Share by Region (2020-2031)

Figure 32. China Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Soliris (Eculizumab) Market Share by Country (2020-2031)

Figure 40. Mexico Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Soliris (Eculizumab) Market Share by Country (2020-2031)

Figure 44. Turkey Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Alexion Revenue Growth Rate in Soliris (Eculizumab) Business (2020-2025)

Figure 48. Bottom-up and Top-down Approaches for This Report

Figure 49. Data Triangulation

Figure 50. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Soliris Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Satralizumab Market Research Report 2025

Global Siltuximab Market Research Report 2024

Global Atezolizumab Market Research Report 2024

Tocilizumab Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global EPIRBs Market Research Report 2024

Global Filgrastim and Biosimilars Market Research Report 2024

Global Elotuzumab Market Research Report 2024

Global Burosumab Market Research Report 2025

Biosimilar Drug Market

Global Cetuximab Biosimilar Market Research Report 2025

Global Belimumab Market Research Report 2024

Global Axitinib Market Research Report 2025

Global Nicosulfuron Market Research Report 2025

Global Nesiritide Market Research Report 2024

Global Trametinib Market Research Report 2025

Global Ramucirumab Market Research Report 2024

Global Tislelizumab Injection Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0I20198

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33W11115

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32E19705

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions